February 15, 2024- Dylan Lawlor is the director of value analysis for Greenville, S.C.-based Prisma Health, which was created by a merger between Greenville Health and Palmetto Health in 2017. He’s been with Prisma Health and Greenville Health since 2002.
“It’s almost guaranteed system to system to be different in the way value analysis is handled because the cultures of every system are different,” Lawlor told The Journal of Healthcare Contracting (JHC), a sister publication of Repertoire, in a recent interview. It was his team’s challenge to merge the two South Carolina health systems’ value analysis programs together and then take on the pandemic.
JHC: Tell us about your professional background.
Lawlor: I’m a lab technologist by trade. I started with 10 years in the military and moved to Greenville in 2002. I started with Greenville Health on third shift in the lab and within about a year was moved into a management position and spent another six years in the lab before moving to supply chain and taking the manager’s role in value analysis.
Back then, we didn’t have a formal program. When we introduced it, the program was very corporate-level and senior-level in terms of what ideas could be applied to find savings for the system. It was more project oriented.
Over the years, it morphed and grew as people realized the value we bring to an equipment review, new product review or capital review. Today, we do it all for Prisma Health. We are connected to anything new coming into the system, even service related. My team pulls together some of the benchmarking, standardizations and quality efforts – making sure that when we implement something, we are doing it as a system.
Read more in the latest issue of Repertoire Magazine.